Mesenchymal Stem Cell Secretome
Vaccineexperimental
Clinical trial activity
15 trials · 14 clinical orgs · 0 marketing orgs
Phase 1
8
Phase 2
8
Phase 3
1
Phase 4
0
Earliest trial started Jun 8, 2020 (NCT04753476)
Timeline
Indications
Studied for
- Arthritis, Rheumatoid · Phase 1/Phase 2
- Cartilage Diseases · Early Phase 1
- Cornea · Early Phase 1
- Corneal Diseases · Phase 2
- COVID-19 · Phase 3
- Crohn Disease · Phase 2
- Cytokine Release Syndrome · Phase 2
- Erectile Dysfunction · Phase 1
- Fertility · Phase 1/Phase 2
- Heart Failure, Systolic · Phase 1
- Infertility, Male · Phase 1/Phase 2
- Knee Injuries · Early Phase 1
- Mesenchymal Stem Cells · Early Phase 1
- Nasopharyngeal Neoplasms · Phase 1/Phase 2
- Oligospermia · Phase 1/Phase 2
- Osteoarthritis · Early Phase 1
- Polycystic Ovary Syndrome · Phase 1/Phase 2
- Teratozoospermia · Phase 1/Phase 2
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigen
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07137130 | N/A | Feb 14, 2026 | University of Indonesia |
| NCT07157891 | Early Phase 1 (Phase 1) | Dec 10, 2025 | University of the Punjab |
| NCT06919081 | Phase 2 | Aug 1, 2025 | National Eye Institute (NEI), National Institutes of Health (NIH), University of Illinois at Chicago |
| NCT06918808 | Phase 2 | May 19, 2025 | Direct Biologics, LLC |
| NCT06839651 | Phase 1 | Apr 21, 2025 | University of Indonesia |
| NCT06869863 | Phase 1/Phase 2 (Phase 2) | Nov 26, 2024 | Moscow State University |
| NCT07245875 | N/A | Apr 12, 2024 | University of Indonesia |
| NCT06066827 | N/A | Aug 14, 2023 | Government of Indonesia, PT. Kimia Farma (Persero) Tbk, University of Indonesia |
| NCT05774509 | Phase 1 | May 31, 2023 | Assistance Publique - Hôpitaux de Paris, Government of France |
| NCT05204329 | Early Phase 1 (Phase 1) | Dec 1, 2022 | National Eye Institute (NEI), National Institutes of Health (NIH), University of Illinois at Chicago |
| NCT05279768 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2022 | Prodia StemCell Indonesia |
| NCT05925647 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2022 | Universitas Sebelas Maret |
| NCT05261750 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2022 | Prodia StemCell Indonesia |
| NCT05122234 | Phase 3 | Aug 10, 2020 | University of Indonesia |
| NCT04753476 | Phase 2 | Jun 8, 2020 | Government of Indonesia, Stem Cell and Cancer Research Indonesia |
Showing 15 of 15 trials
Page 1 / 1
Organizations
Research & Development (14)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Indonesia | Academic/Hospital | 5 | 5 | 3 | 2020 |
| Government of Indonesia | Government | 2 | 0 | 2 | 2020 |
| National Eye Institute (NEI) | Government | 2 | 0 | 2 | 2022 |
| National Institutes of Health (NIH) | Government | 2 | 0 | 2 | 2022 |
| Prodia StemCell Indonesia | For profit | 2 | 2 | 1 | 2022 |
| University of Illinois at Chicago | Academic/Hospital | 2 | 2 | 2 | 2022 |
| Assistance Publique - Hôpitaux de Paris | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Direct Biologics, LLC | For profit | 1 | 1 | 1 | 2025 |
| Government of France | Government | 1 | 0 | 1 | 2023 |
| Moscow State University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| PT. Kimia Farma (Persero) Tbk | For profit | 1 | 0 | 1 | 2023 |
| Stem Cell and Cancer Research Indonesia | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Universitas Sebelas Maret | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of the Punjab | Academic/Hospital | 1 | 1 | 1 | 2025 |
14 organizations
Page 1 / 1